[Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
Dausse Jp, Pascale Guicheney, Maich Pj, P Meyer
Abstract
Dausse Jp, Pascale Guicheney, Maich Pj, P Meyer
Abstract
The interaction of a new antihypertensive agent, labetalol was demonstrated in subcellular preparations enriched in alpha- and beta-adrenergic receptors. This result give direct confirmation of pharmacological data observed in isolated organs and in vivo. It illustrates the value of biochemical studies of receptors in order to define the mechanism of action of drugs.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The interaction of a new antihypertensive agent, labetalol was demonstrated in subcellular preparations enriched in alpha- and beta-adrenergic receptors. This result give direct confirmation of pharmacological data observed in isolated organs and in vivo. It illustrates the value of biochemical studies of receptors in order to define the mechanism of action of drugs.
Key concepts: Labetalol, Adrenergic receptor, Alpha (finance), BETA (programming language), Receptor, Pharmacology, Mechanism of action, Sympatholytics